Freestone Capital Holdings’s Adaptive Biotechnologies ADPT Stock Holding History

Freestone Capital Holdings’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.23M	Buy	+103,753	New	+$1.59M	0.06%	189

Other funds holding ADPT

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

AWM

Affinity Wealth Management Wilmington, Delaware $776M AUM 43.59% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

KOCAA

Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

Freestone Capital Holdings's ADPT Position: Q2 2026 in Review

Freestone Capital Holdings opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 103,753 shares worth $2.23M. The stake represents 0.06% of the portfolio and ranks #189 among its holdings.

73 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Freestone Capital Holdings held 103,753 shares of Adaptive Biotechnologies worth $2.23M as of Q2 2026.
Adaptive Biotechnologies was a new Freestone Capital Holdings position in Q2 2026.
Adaptive Biotechnologies made up 0.06% of Freestone Capital Holdings's portfolio in Q2 2026, its #189 holding.
73 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.